MESA LABORATORIES INC CO

For the period ended Dec 31, 2024. Filed Feb 4, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 4, 2025

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

	Three Months Ended December 31,		Nine Months Ended December 31,
	2024	2023	2024	2023
Revenues	$62,840	$53,473	$178,843	$157,283
Cost of revenues	23,086	20,071	66,385	60,589
Gross profit	39,754	33,402	112,458	96,694
Operating expense:
Selling	10,450	9,737	30,415	28,363
General and administrative	18,472	19,438	52,754	55,024
Research and development	5,053	4,294	14,422	14,098
Total operating expense	33,975	33,469	97,591	97,485
Operating income (loss)	5,779	(67)	14,867	(791)
Non-operating expense:
Interest expense and amortization of debt issuance costs	2,842	1,856	9,340	3,809
(Gain) on extinguishment of convertible senior notes	-	-	(2,887)	-
Other expense (income), net	5,154	(3,869)	2,914	(4,284)
Total non-operating expense (income), net	7,996	(2,013)	9,367	(475)
(Loss) earnings before income taxes	(2,217)	1,946	5,500	(316)
Income tax (benefit) expense	(541)	(170)	360	(653)
Net (loss) income	$(1,676)	$2,116	$5,140	$337
(Loss) earnings per share:
Basic	$(0.31)	$0.39	$0.95	$0.06
Diluted	$(0.31)	$0.39	$0.94	$0.06
Weighted-average common shares outstanding:
Basic	5,429	5,393	5,413	5,384
Diluted	5,429	5,396	5,464	5,394

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.